Kwick Forensic Solutions IPO Details
Kwick Forensic Solutions IPO Summary

Kwick Forensic Solutions IPO opens for subscription on 27 Aug 2026 and closes on 31 Aug 2026.The IPO will be listed on BSE with the tentative listing date set for 03 Sep 2026.
Kwick Forensic Solutions IPO price band has been fixed at ₹85 – ₹90 per share. The face value is ₹10 per share with a lot size of 1600.
Kwick Forensic Solutions IPO total issue size comprises 56,41,600 shares (aggregating up to ₹50.77 Cr). This includes a fresh issue of 45,61,600 shares (aggregating up to ₹41.05 Cr). Offer for Sale consists of 10,80,000 shares (aggregating up to ₹9.72 Cr). Pre-issue shareholding stands at 1,68,74,840, which will increase to 2,14,36,440 post-issue.
Kwick Forensic Solutions IPO carries a ₹64 (71.11%) GMP, reflecting investor sentiment.
Kwick Forensic Solutions IPO Lot Size :Individual Minimum is 2 lots (3,200 shares) amounting to ₹288,000. Individual Maximum is 2 lots (3,200 shares) amounting to ₹288,000. SHNI Minimum is 3 lots (4,800 shares) amounting to ₹432,000. SHNI Maximum is 6 lots (9,600 shares) amounting to ₹864,000. BHNI Minimum is 7 lots (11,200 shares) amounting to ₹1,008,000.
Kwick Forensic Solutions IPO Details
Kwick Forensic Solutions IPO Subscription
Kwick Forensic Solutions IPO Application Wise Breakup
Kwick Forensic Solutions IPO Dates
- 27 Aug 2026Opening dateOpen
- 31 Aug 2026Closing dateClose
- 01 Sep 2026Allotment Date Allotment
- 02 Sep 2026Initiation of RefundsRefund
- 02 Sep 2026Credit of SharesCredit
- 03 Sep 2026Listing dateListing
Kwick Forensic Solutions IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual Minimum | 2 | 3200 | ₹288,000 |
| Individual Maximum | 2 | 3200 | ₹288,000 |
| SHNI Minimum | 3 | 4800 | ₹432,000 |
| SHNI Maximum | 6 | 9600 | ₹864,000 |
| BHNI Minimum | 7 | 11200 | ₹1,008,000 |
Kwick Forensic Solutions IPO Reservation
Promoter Holding
Documents
Kwick Forensic Solutions IPO Valuations
Kwick Forensic Solutions Financial Information
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 60.53 | 46.79 | 19.19 |
| Total Income | 105.80 | 65.08 | 30.26 |
| Profit After Tax | 13.51 | 8.56 | 2.83 |
| EBITDA | 19.06 | 12.25 | 5.45 |
| NET Worth | 41.41 | 27.90 | 9.86 |
| Reserves and Surplus | 24.53 | 25.79 | 7.93 |
| Total Borrowing | 3.26 | 3.24 | |
| Amount in ₹ Crore | |||
About Kwick Forensic Solutions IPO
Incorporated in March 2005, Kwick Forensic Solutions Limited (formerly Kwick Soft Solutions Private Limited) is engaged in providing forensic science, evidence management, cyber and digital forensics, DNA forensics and law-enforcement solutions across India. The Company initially focused on software development, including 3D rendering, animation and simulation, and subsequently expanded into forensic science and training technologies. Since FY2015, it has developed and supplied end-to-end forensic products, solutions, tools and technologies for crime scene investigation, fingerprint science, cyber/digital forensics, social-media analytics and evidence management.
The Company offers a diversified portfolio of forensic products and services, including fingerprint and physical evidence kits, evidence collection kits, Mobile Crime Scene Investigation Vehicles, digital forensic tools, DNA forensic solutions, handheld forensic devices and rental services for forensic equipment. It also provides product demonstrations, operating training, installation and post-delivery technical support. Its customers include police departments, central and state forensic laboratories, fingerprint bureaus, crime investigation departments, police training academies, universities and other government and private-sector institutions. The Company also sources products from international and domestic OEMs and has progressively increased domestic procurement to support supply continuity and cost efficiency.
The Company is supported by R&D and quality-management capabilities, including a branch facility used for R&D, product demonstrations and proof-of-concept forensic laboratory activities. Its quality systems are supported by ISO 9001:2015, ISO 14001:2015, ISO/IEC 20000-1:2018 and ISO/IEC 27001:2022 certifications, along with registrations with MSME, DSIR and NSIC.
As of July 31, 2026, the Company had 33 employees on payroll and 12 employees on contract, with personnel deployed across administration, finance, legal and compliance, operations, R&D, sales and marketing, tendering and management functions.
Strength Of Kwick Forensic Solutions IPO
- Experienced Promoter and management team with strong industry expertise and successful track record.
- Diversified revenue streams.
- Deep relationships with government/law-enforcement clients.
- Long-standing OEM relationships.
- Pan-India presence.
- Highly passionate & focused on Quality Assurance, backed by ISO certifications.
- Efficient operational team.
Risk Of Kwick Forensic Solutions IPO
- Our products and services are significantly concentrated in the certain states, particularly Bihar and Gujarat. Any adverse developments in these regions may materially impact our business, financial condition, results of operations, and cash flows.
- We do not have long-term agreements with a majority of our customers. Any changes or cancellations to our orders or our inability to forecast demand for our products may adversely affect our business, results of operations and financial condition.
- We derive majority of our revenue from Sales of Goods and Sales of Services and any reduction in the demand of such segment could have an adverse effect on our business, results of operations and financial conditions.
- The average cost of acquisition of Equity Shares by our Promoters Selling Shareholders could be lower than the Offer price determined in consultation with Book Running Lead Manager in accordance with the SEBI ICDR Regulations.
- Any delays in filing Advance Tax, EPF, GST returns, TDS Return may lead to regulatory penalties and may have an adverse impact on our financial and operational performance.
- We are dependent on a limited number of suppliers for procurement of our raw materials, and the loss of any one or more of our major suppliers would have a material adverse effect on our business operations and profitability.
- There have been instances in the past where our forensic product activities were not being aligned with the main object clause of our Memorandum of Association.
- We source our products from the international market i.e. China, USA, Turkey, Japan, Italy etc. Any adverse developments affecting our procurement in this region could materially and adversely impact our revenue and results of operations.
- Our Company had negative cash flows in the past years, details of which are given below. Sustained negative cash flow could impact our growth and business.
- Our company drive 55.22%, 78.91% and 86.98%, in FY 2026, 2025 and 2024 revenue from business transactions with government entities or agencies. Any change in the governments in the markets in which we operate, change in policies and/or our inability to recover payments therefrom in a timely manner or at all, would adversely affect our operations and revenues which in turn would adversely affect our profitability.
Objectives Kwick Forensic Solutions IPO
1. Funding the Working Capital requirement of our Company
2. General Corporate Purposes
Company Contact Details
Kwick Forensic Solutions Ltd.
New No 12 Old No 11 East Park Road,
Shenoy Nagar
Chennai, Tamil Nadu, 600030
Phone: +91-8807110249
Email: cs@kwickforensic.com
Website: https://kwickforensic.com/
Registrar Contact Details
Kwick Forensic Solutions FAQs
The Kwick Forensic Solutions IPO is a SME public issue comprising 5641600 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹50.77 Cr. The issue price has been fixed at ₹90 per equity share, and the minimum application size is 1600 shares.
The IPO opens for subscription on 27 Aug 2026, and closes on 31 Aug 2026.
Bigshare Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the BSE
As of now, the current GMP stands at ₹64 (71.11%).

